Beijing Hotgen Biotech Co Ltd (688068) — Free Cash Flow Generation Index

Latest as of September 2025: -3.82x

Beijing Hotgen Biotech Co Ltd (688068) has a Free Cash Flow Generation Index of -3.82x as of September 2025. Free cash flow of CN¥-11.68 Million represents -4% of operating cash flow (CN¥3.05 Million). Explore 688068 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

-3.82x
Free Cash Flow / Operating CF

Free Cash Flow

CN¥-11.68 Million
CNY

Operating Cash Flow

CN¥3.05 Million
CNY

Capital Expenditures

CN¥14.73 Million
CNY

Beijing Hotgen Biotech Co Ltd Free Cash Flow Generation Index (2016–2022)

Historical FCF Generation Index trend for Beijing Hotgen Biotech Co Ltd across 7 annual periods. For the full cash flow conversion analysis, see Beijing Hotgen Biotech Co Ltd (688068) cash conversion ratio.

Annual Free Cash Flow Generation for Beijing Hotgen Biotech Co Ltd (2016–2022)

Year-by-year Free Cash Flow Generation Index for Beijing Hotgen Biotech Co Ltd. Check Beijing Hotgen Biotech Co Ltd (688068) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (CNY) Operating CF Capital Expenditures YoY Change
2022 0.42x CN¥413.54 Million CN¥978.75 Million CN¥565.21 Million ▼ -50.2%
2021 0.85x CN¥2.25 Billion CN¥2.64 Billion CN¥398.86 Million ▲ +1928.4%
2020 -0.05x CN¥-7.65 Million CN¥164.62 Million CN¥172.27 Million ▲ +98.7%
2019 -3.57x CN¥-69.11 Million CN¥19.37 Million CN¥88.48 Million ▼ -1606.4%
2018 0.24x CN¥13.03 Million CN¥55.04 Million CN¥42.00 Million ▲ +111.8%
2017 -2.01x CN¥-46.10 Million CN¥22.95 Million CN¥69.05 Million ▼ -475.5%
2016 0.53x CN¥24.36 Million CN¥45.54 Million CN¥21.18 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).